“Interstitial Cystitis - Pipeline Insights, 2015” – A DelveInsight’s Report

NEW DELHI - Sept. 9, 2015 - PRLog -- The Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2015 reports provides the client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

·14+ pipeline drugs with 7+ companies actively involved in drug development. There are 6 drugs in phase II, 2 in phase I, 5 in pre-clinical and 1 in discovery.

·Afferent Pharmaceuticals developing a lead product AF-219 whichis in Phase II.

·R&D activities and technologies used along with the pipeline molecules in development.

·Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

·Information related to  collaborarions, in-licensing and out-licensing deals.

DelveInsights, Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2015 report provides the in-depth analysis of Interstitial Cystitis Landscape across the globe. Therefore the report on Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights provides information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.